NVCR
NovoCure Limited
NASDAQ · Healthcare · Medical - Instruments & Supplies · JE
$17.94
+1.70%Margins
Gross margin
76.1%
EBITDA margin
-19.2%
EBIT margin
-22.1%
Net margin
-21.2%
FCF margin
-3.0%
-43.9%
Return on equity
-18.7%
Return on assets
-27.0%
Return on invested capital
0.88x
Asset turnover
$1.5M
Cash from operations
$3.78
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026